NexGel, Inc Common Stock (NXGL) Stock Price

NXGLStock

$5.59−88.16%52W

Market Cap$2.72M

P/E—

PEG Ratio—

Div yield—

Beta0.76

NXGL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-62.89%

Price vs S&P 500 (4W)6.80%

VGM Score53.81

Book Value / Share (Quarterly)$0.51

P/TBV (Annual)4.57x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)77.28%

Cash Flow / Share (Quarterly)$-1.01

Price vs S&P 500 (YTD)-94.57%

Gross Margin (TTM)35.07%

Net Profit Margin (TTM)-51.26%

EPS (TTM)$-0.72

10-Day Avg Trading Volume0.45M

EPS Excl Extra (TTM)$-0.72

Revenue Growth (5Y)76.33%

EPS (Annual)$-0.38

ROI (Annual)-56.03%

Gross Margin (Annual)39.48%

Net Profit Margin (5Y Avg)-130.20%

Cash / Share (Quarterly)$0.05

Revenue Growth QoQ (YoY)27.81%

ROA (Last FY)-28.68%

Revenue Growth TTM (YoY)3.38%

EBITD / Share (TTM)$-0.52

ROE (5Y Avg)-57.86%

Operating Margin (TTM)-46.93%

Cash Flow / Share (Annual)$-0.17

P/B Ratio3.47x

P/B Ratio (Quarterly)0.93x

Net Income / Employee (Annual)$-157,900

EV / Revenue (TTM)1.70x

Net Interest Coverage (TTM)-84.09x

ROA (TTM)-41.15%

EPS Incl Extra (Annual)$-0.38

Current Ratio (Annual)1.47x

Quick Ratio (Quarterly)0.19x

3-Month Avg Trading Volume0.08M

52-Week Price Return-88.16%

Revenue / Employee (TTM)$635,100

Tangible BV / Share (Quarterly)$0.39

P/S Ratio (Annual)1.50x

Asset Turnover (Annual)1.09x

52-Week High$57.00

Operating Margin (5Y Avg)-94.86%

EPS Excl Extra (Annual)$-0.38

CapEx CAGR (5Y)-26.17%

26-Week Price Return-52.99%

Quick Ratio (Annual)0.59x

13-Week Price Return-40.72%

Total Debt / Equity (Annual)0.20x

Current Ratio (Quarterly)0.43x

Enterprise Value$20.55M

Revenue / Share Growth (5Y)64.61%

Asset Turnover (TTM)0.80x

Revenue / Employee (Annual)$601,100

Inventory Turnover (Annual)3.58x

Pretax Margin (Annual)-25.33%

Cash / Share (Annual)$0.04

3-Month Return Std Dev171.83%

Gross Margin (5Y Avg)19.92%

Net Income / Employee (TTM)$-325,500

ROE (Last FY)-67.28%

Net Interest Coverage (Annual)-1.38x

EPS Basic Excl Extra (Annual)$-0.38

Receivables Turnover (TTM)13.17x

Total Debt / Equity (Quarterly)0.78x

EPS Incl Extra (TTM)$-0.72

Receivables Turnover (Annual)14.22x

ROI (TTM)-93.53%

P/S Ratio (TTM)1.42x

Pretax Margin (5Y Avg)-130.59%

Revenue / Share (Annual)$1.45

Tangible BV / Share (Annual)$0.46

Forward P/E3.81x

Price vs S&P 500 (52W)-103.69%

Year-to-Date Return-82.64%

5-Day Price Return46.72%

EPS Normalized (Annual)$-0.38

ROA (5Y Avg)-32.30%

Net Profit Margin (Annual)-26.27%

Month-to-Date Return61.56%

Cash Flow / Share (TTM)$-0.45

EBITD / Share (Annual)$-0.31

Operating Margin (Annual)-27.93%

LT Debt / Equity (Annual)0.11x

ROI (5Y Avg)-50.24%

LT Debt / Equity (Quarterly)0.71x

EPS Basic Excl Extra (TTM)$-0.72

P/TBV (Quarterly)1.61x

P/B Ratio (Annual)3.87x

Inventory Turnover (TTM)3.80x

Pretax Margin (TTM)-50.16%

Book Value / Share (Annual)$0.55

Price vs S&P 500 (13W)-43.41%

Beta0.76x

Revenue / Share (TTM)$1.34

ROE (TTM)-133.10%

52-Week Low$3.00

vGradeB

gGradeB

mGradeD

vgmGradeC

NXGL Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 17, 2026	-$2.40	-$10.32	-329.83%(-$7.92)
Q1 2026	May 14, 2026	-$1.40	-$2.20	-57.14%(-$0.80)
Q4 2025	Mar 31, 2026	-$1.80	-$2.98	-65.33%(-$1.18)
Q3 2025	Nov 12, 2025	—	-$1.60	—
Q2 2025	Aug 12, 2025	-$0.07	-$0.10	-41.14%(-$0.03)

NXGL Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.14

2.17

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
NXGLNexGel, Inc Common Stock	B	B	D	1.4x	76.3%	35.1%	-46.9%	$5.59
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About NexGel, Inc Common Stock

NexGel Inc manufactures aqueous polymer hydrogels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics applications. The company differentiates through proprietary manufacturing technologies, including electron beam cross-linking, that enable specialized custom gel development.

NXGL Next Earnings Report

Report dateNov 10, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$4.80

Revenue estimate$4.19M

Also reporting on Nov 10, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

MITQMoving iMage Technologies, Inc.Photographic Equipment & Supplies
APMAptorum Group Limited Class A Ordinary SharesMeasuring & Controlling Devices
FCUVFocus Universal Inc. Common StockIndustrial Instruments
POASPhaos Technology Holdings (Cayman) LimitedIndustrial Instruments
NXLNexalin Technology, Inc. Common StockElectromedical Equipment
NUWENuwellis, Inc. Common StockElectromedical Equipment
BBLGBone Biologics Corp Common StockOrthopedic & Prosthetic Devices
FEEDENvue Medical, Inc. Common StockOrthopedic & Prosthetic Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

2.2

Sell

Consensus rating

52-Week Range

Low$3.00

High$57.00